Bayer to Pay Over $10 Billion in Roundup Cancer Settlement

Contact Us To Learn Your Potential Legal Options At No Cost.

If you have been diagnosed with non-Hodgkin’s lymphoma, you may be able to receive compensation from the settlement.

"*" indicates required fields

# Roundup Lawsuit

Roundup Settlement Includes $1.25 Billion for Future Claims

In June 2020, Monsanto maker Bayer agreed to pay $10 billion to settle tens of thousands of lawsuits linking the popular weedkiller to non-Hodgkin’s lymphoma. This includes $1.25 billion set aside to handle future claims.

“It’s rare that we see a consensual settlement with that many zeros on it,” said Nora Freeman Engstrom, a professor at Stanford University Law School.

–The New York Times, “Roundup Maker to Pay $10 Billion to Settle Cancer Suits”

This isn’t the first major ruling against Monsanto in the Roundup litigation. In 2018, a groundskeeper was awarded $289 million. In March 2019, a homeowner who used Roundup was awarded $80 million. A few months later, a couple was award $2 billion after decades of Roundup use.

Non-Hodgkin Lymphoma Risks.

The American Cancer Society lists exposure to certain chemicals like herbicides as a potential risk factor for developing non-Hodgkin lymphoma. People who used Roundup on a consistent basis, whether commercially or residentially, are at most risk for developing NHL. If you used Roundup and have a diagnosis of NHL, please contact us to learn more about your legal options.

Learn More

A Probable Carcinogen Made More Lethal By A Potential Cover-Up?

The herbicide Glyphosate, Roundup’s key ingredient, was deemed a PROBABLE human carcinogen by the World Health Organization in 2015. Glyphosate is currently the biggest seller of all herbicides, approaching $5 billion in annual sales. Its use has skyrocketed since the development of genetically modified crops that are resistant to glyphosate.

Although some studies point to glyphosate’s safety, there is clear evidence that Monsanto used its money and power to influence the outcome of studies that could have a negative bearing on sales. As found in Monsanto’s internal emails, a company executive bragged that an EPA official, upon offering to help quash another agency’s review of glyphosate, said “If I can kill this I should get a medal.”

You should not be alone in your fight for your life.